Protocol · Neurological Health
ALS Supportive Care Protocol
Vitamin D and Coenzyme Q10 are the core of this stack, with 6 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in ALS Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
8 supplements · 1 graded
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Vitamin D | Amount listed: 2,000–5,000 IU daily (target 40–60 ng/mL, monitor levels) | Deficiency common in ALS; neuroprotective effects; may support muscle function | Not graded yet | |
| Coenzyme Q10 | Amount listed: 300–1,200 mg daily in divided doses | Supports mitochondrial function; antioxidant properties may help protect motor neurons | Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Creatine | Amount listed: 5–10 g daily | Supports energy metabolism in muscles; may help maintain muscle strength
| Grade D for Amyotrophic Lateral Sclerosis Symptoms6 studies · 386 people | |
| Omega-3 Fatty Acids | Amount listed: 2–3 g EPA+DHA daily | Anti-inflammatory and neuroprotective effects; may support overall health | Not graded yet | |
| Vitamin E | Amount listed: 400–2,000 IU daily (mixed tocopherols) | Antioxidant; may help reduce oxidative stress contributing to motor neuron damage | Not graded yet | |
| B Vitamins | Amount listed: B-complex with B12 1,000 mcg, folate 800 mcg daily | Support nerve function and energy metabolism; B12 particularly important for neurological health | Not graded yet | |
| Alpha-Lipoic Acid | Amount listed: 600–1,200 mg daily | Antioxidant that crosses blood-brain barrier; may help reduce oxidative stress | Not graded yet | |
| Protein Supplementation | Amount listed: 1.2–1.5 g protein per kg body weight daily | Maintains muscle mass and nutritional status; essential for ALS patients with swallowing difficulties | Not graded yet | |
How this protocol works
In plain language
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects motor neurons - the nerve cells that control voluntary muscles. As motor neurons die, the brain loses the ability to control muscle movement, leading to progressive weakness, muscle wasting, and eventually paralysis. ALS typically affects both upper and lower motor neurons, causing a combination of weakness, muscle twitching, stiffness, and atrophy.
CRITICAL: ALS is a serious, progressive disease requiring specialized neurological care at an ALS center if possible. FDA-approved treatments include riluzole (which may extend survival) and edaravone (which may slow functional decline in some patients). Comprehensive care including respiratory support, nutritional management, physical therapy, and speech therapy is essential. NO supplement has been proven to slow ALS progression. These supplements support overall health and address common deficiencies but should never replace or delay proper medical care.
Vitamin D* deficiency is very common in ALS patients and may contribute to muscle weakness. Maintaining adequate vitamin D levels supports muscle function and may have neuroprotective effects.
Coenzyme Q10* supports mitochondrial function. Mitochondrial dysfunction is implicated in ALS, and CoQ10 has shown some promise in early studies, though large trials haven't confirmed benefit.
Creatine* supports muscle energy metabolism. While Cochrane review didn't find clear evidence of benefit in ALS, it may help maintain muscle strength in some patients.
Omega-3 Fatty Acids* have anti-inflammatory and neuroprotective properties that may support overall health in ALS patients.
Vitamin E* is an antioxidant that may help reduce oxidative stress, which is elevated in ALS.
B Vitamins* support nerve function and energy metabolism. B12 is particularly important for neurological health.
Alpha-Lipoic Acid* is an antioxidant that crosses the blood-brain barrier and may help protect neurons from oxidative damage.
Protein Supplementation* is critical in ALS because maintaining weight and muscle mass is associated with better outcomes. Many ALS patients develop swallowing difficulties that make adequate nutrition challenging.
Expected timeline: No supplement should be expected to reverse ALS progression. The focus is on maintaining quality of life, nutritional status, and overall health. ALS progression varies widely - average survival is 3-5 years from diagnosis, but some patients live much longer.